Search Results for "FluMist"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for FluMist. Results 1 to 4 of 4 total matches.
See also: vaccine, influenza
In Brief: FluMist Influenza Vaccine for Self-Administration
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
In Brief: FluMist Influenza Vaccine for Self-Administration ...
FluMist (AstraZeneca), the live-attenuated intranasal
influenza vaccine that has been available for
years for administration by a healthcare provider
in nonpregnant persons 2-49 years old, has now
been approved by the FDA for self- or caregiver-administration.
It is expected to be available for such
use during the 2025-2026 influenza season. FluMist
is only available through a healthcare provider
this season. It will continue to be available for
administration by a healthcare provider in the future
Med Lett Drugs Ther. 2024 Oct 28;66(1714):174-5 doi:10.58347/tml.2024.1714c | Show Introduction Hide Introduction
Influenza Vaccines for 2025-2026
The Medical Letter on Drugs and Therapeutics • Sep 29, 2025 (Issue 1738)
(Sanofi)15 0.5 mL syringe ≥9 years 78.40
Live-Attenuated Trivalent (LAIV3); Egg-based
FluMist ...
Annual vaccination against influenza A and B viruses
is recommended in the US for everyone ≥6 months
old without a contraindication. Influenza vaccines
available in the US for the 2025-2026 season are listed
in Table 2.
Med Lett Drugs Ther. 2025 Sep 29;67(1738):153-8 doi:10.58347/tml.2025.1738a | Show Introduction Hide Introduction
Comparison Table: Antiviral Drugs for Seasonal Influenza for 2025-2026 (online only)
The Medical Letter on Drugs and Therapeutics • Oct 27, 2025 (Issue 1740)
With Intranasal Live-Attenuated Influenza Vaccine (FluMist, FluMist Home)7:
▪ Antivirals could inhibit ...
View the Comparison Table: Antiviral Drugs for Seasonal Influenza for 2025-2026
Med Lett Drugs Ther. 2025 Oct 27;67(1740):e178-80 doi:10.58347/tml.2025.1740d | Show Introduction Hide Introduction
Antiviral Drugs for Seasonal Influenza for 2025-2026
The Medical Letter on Drugs and Therapeutics • Oct 27, 2025 (Issue 1740)
within
17 days before administration of the live-attenuated
intranasal influenza vaccine (FluMist ...
Influenza is generally a self-limited illness, but complications
including pneumonia, respiratory failure, and
death can occur, especially in persons at increased
risk (see Table 1).
Med Lett Drugs Ther. 2025 Oct 27;67(1740):169-74 doi:10.58347/tml.2025.1740a | Show Introduction Hide Introduction